Today's Veterinary Practice

MAR-APR 2018

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: https://todaysveterinarypractice.epubxp.com/i/952104

Contents of this Issue

Navigation

Page 42 of 95

37 MARCH/APRIL 2018 ● TVPJOURNAL.COM CONTINUING EDUCATION Finding the Balance in Your Patients with Cardiovascular and Renal Disease 1. Examples of cardiovascular disease processes that lead to kidney dysfunction include a. Systemic hypertension b. Heartworm disease c. Low cardiac output d. All 2. A biomarker that is useful for detecting early chronic kidney disease in dogs and cats and that correlates well with measurements of glomerular filtration rate is a. Angiotensin II b. Cardiac troponin I c. N-terminal pro b-type natriuretic peptide (NT- proBNP) d. Serum symmetric dimethylarginine (SDMA) 3. Idiopathic tubulo-interstitial disease is the most common renal pathology in cats. a. True b. False 4. You are presented with a 10-year-old Miniature Poodle with degenerative valve disease and stable CHF managed with benazepril, furosemide, and pimobendan. Blood pressure is within normal range. The most recent biochemistry panel documents azotemia. Select the ideal next step for this dog: a. Decrease the pimobendan b. Decrease the furosemide c. Increase the benazepril d. Administer subcutaneous fluid therapy 5. Systolic blood pressure increases the risk for target organ damage when it is a. <120 mmHg b. 120–140 mmHg c. 140–160 mmHg d. >180 mmHg NOTE Questions online may differ from those here; answers are available once CE test is taken at vetfolio.com/journal-ce . Tests are valid for 2 years from date of approval. LEARNING OBJECTIVES After reading this article, participants will be able to explain the complex physiology between the heart and kidneys, classify cardiovascular and renal disorders according to primary disease process, create a diagnostic plan, and make management recommendations based on clinical considerations in an individual canine or feline patient. TOPIC OVERVIEW This article discusses cardio-renal disease in dogs and cats including diagnosis and management strategies. The article you have read has been submitted for RACE approval for 1 hour of continuing education credit and will be opened for enrollment when approval has been received. To receive credit, take the approved test online for free at vetfolio.com/journal-ce . Free registration on VetFolio.com is required. Questions and answers online may differ from those below. Tests are valid for 2 years from the date of approval. CONTINUING EDUCATION 6. Nonsteroidal anti-inflammatory drugs cause ___________ of the afferent arterioles of the kidneys, and ACE inhibitors cause ___________of the efferent arterioles; the combined effect can reduce glomerular filtration rate. a. Vasoconstriction, vasoconstriction b. Vasoconstriction, vasodilation c. Vasodilation, vasodilation d. Vasodilation, vasoconstriction 7. Which of the following is a useful screening test for preclinical heart disease in cats? a. Cardiac auscultation b. Measurement of systolic blood pressure c. Measurement of N-terminal pro b-type natriuretic peptide (NT-proBNP) d. Electrocardiography (ECG) 8. Subcutaneous fluid therapy is superior to intravenous fluid therapy in cats with renal disease and concurrent cardiac disease. a. True b. False 9. The electrolyte disorder most often associated with diuretic use is a. Hypokalemia b. Hypomagnesemia c. Hyperkalemia d. Hypernatremia 10. Which of the following serum biochemical parameters should be rechecked within 14 days of starting an ACE inhibitor? a. Phosphorus b. Sodium c. Creatinine d. Albumin

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Practice - MAR-APR 2018